Key result
Losartan administration resulted in a threefold decrease in interstitial and perivascular fibroblast proliferation (p < .05) in rats with phenylephrine-induced cardiac fibrosis.
Why the study?
Does angiotensin II blockade with losartan reduce phenylephrine-induced cardiac fibrosis in adult Wistar rats?
Does angiotensin II blockade with losartan reduce phenylephrine-induced cardiac fibrosis in adult Wistar rats?
Effect estimate: threefold decrease
p-value: p=< .05
Angiotensin II blockade with losartan significantly reduces alpha-1-adrenergic-mediated cardiac fibrosis and fibroblast proliferation in a rat model.
May implicate angiotensin II in rapid cardiac fibrosis; leaves open translation to human hypertension.
In this study we infused phenylephrine into adult Wistar rats and used losartan to test for a possible role of angiotensin II in the phenylephrine-induced fibrosis. Phenylephrine, given by Alzet minipumps at a rate of 25 mg.kg-1.d-1, produced a rapid and striking fibrotic response that was obvious after 1 day and progressed throughout a 3-day infusion period. Northern and Western blot analyses showed large increases in cardiac fibronectin expression and atrial natriuretic peptide mRNA, corresponding to fibroblast proliferation and myocyte hypertrophy, respectively. Cardiac fibrosis, fibronectin mRNA, and atrial natriuretic peptide mRNA were blocked by prazosin (7 mg.kg-1.d-1). Administration of losartan (10 mg.kg-1.d-1) resulted in a threefold decrease in interstitial and perivascular fibroblast proliferation, as measured by proliferating cell nuclear antigen immunoreactivity (p < .05), a marked reduction of fibronectin mRNA in the heart, and a moderate reduction of cardiac atrial natriuretic peptide mRNA. The data suggest that effects mediated by a1-adrenergic and angiotensin type 1 receptors may promote cardiac fibrosis.
No takes yet. Share an insight, caveat, or question.
Farivar et al. (1995) studied Phenylephrine-induced cardiac fibrosis. Losartan was evaluated on Interstitial and perivascular fibroblast proliferation (threefold decrease, p=< .05). Losartan administration resulted in a threefold decrease in interstitial and perivascular fibroblast proliferation (p < .05) in rats with phenylephrine-induced cardiac fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: